1. Home
  2. MDXH vs TKNO Comparison

MDXH vs TKNO Comparison

Compare MDXH & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.98

Market Cap

149.0M

Sector

N/A

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$3.71

Market Cap

138.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDXH
TKNO
Founded
2003
1996
Country
Belgium
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.0M
138.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
MDXH
TKNO
Price
$0.98
$3.71
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$7.67
N/A
AVG Volume (30 Days)
147.5K
89.9K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.86
EPS
N/A
N/A
Revenue
N/A
$40,520,000.00
Revenue This Year
$30.78
$8.27
Revenue Next Year
$18.31
$13.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.35
52 Week Low
$1.82
$1.91
52 Week High
$5.33
$6.86

Technical Indicators

Market Signals
Indicator
MDXH
TKNO
Relative Strength Index (RSI) 14.78 57.80
Support Level N/A $3.60
Resistance Level $2.30 $4.37
Average True Range (ATR) 0.12 0.32
MACD -0.04 0.02
Stochastic Oscillator 3.10 45.77

Price Performance

Historical Comparison
MDXH
TKNO

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: